DCF Advisers, LLC - Q1 2023 holdings

$163 Million is the total value of DCF Advisers, LLC's 67 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 100.0% .

 Value Shares↓ Weighting
SPY BuySPDR S&P 500 ETF TRput$25,177,490
+109.0%
61,500
+95.2%
15.41%
+89.3%
ARGX BuyARGENX SEsponsored adr$9,575,310
+1.1%
25,700
+2.8%
5.86%
-8.4%
MU BuyMICRON TECHNOLOGY INC$9,503,550
+22.7%
157,500
+1.6%
5.82%
+11.1%
REGN BuyREGENERON PHARMACEUTICALS$9,058,910
+15.2%
11,025
+1.1%
5.55%
+4.3%
XNCR BuyXENCOR INC$5,856,900
+9.2%
210,000
+2.0%
3.58%
-1.1%
ET BuyENERGY TRANSFER L P$4,663,780
+6.9%
374,000
+1.8%
2.86%
-3.2%
PRTA BuyPROTHENA CORP PLC$4,083,600
-8.5%
84,250
+13.7%
2.50%
-17.1%
AMGN NewAMGEN INC$2,417,50010,000
+100.0%
1.48%
JQC BuyNUVEEN CR STRATEGIES INCOME$1,860,040
+17.3%
364,000
+16.9%
1.14%
+6.3%
TPB NewTURNING PT BRANDS INC$1,745,37083,113
+100.0%
1.07%
PFE BuyPFIZER INC$1,642,200
-11.6%
40,250
+11.0%
1.00%
-19.9%
NewESPERION THERAPEUTICS INC NEnote 4.000%11/1$1,476,0003,600,000
+100.0%
0.90%
VIR BuyVIR BIOTECHNOLOGY INC$1,442,740
+137.5%
62,000
+158.3%
0.88%
+114.8%
BIIB NewBIOGEN INC$1,362,3504,900
+100.0%
0.83%
BABA BuyALIBABA GROUP HLDG LTDsponsored ads$1,287,470
+124.9%
12,600
+93.8%
0.79%
+103.6%
AMGN NewAMGEN INCcall$1,063,7004,400
+100.0%
0.65%
MRVL BuyMARVELL TECHNOLOGY INC$974,250
+50.3%
22,500
+28.6%
0.60%
+36.1%
LNSR BuyLENSAR INC$873,350
-14.7%
350,742
+1.4%
0.54%
-22.7%
PAAS BuyPAN AMERN SILVER CORP$819,000
+54.2%
45,000
+38.5%
0.50%
+39.6%
GOLD BuyBARRICK GOLD CORP$742,800
+44.1%
40,000
+33.3%
0.46%
+30.7%
MU NewMICRON TECHNOLOGY INCput$603,40010,000
+100.0%
0.37%
INTC NewINTEL CORP$571,73017,500
+100.0%
0.35%
IMPL BuyIMPEL PHARMACEUTICALS INC$536,410
-56.1%
383,148
+17.6%
0.33%
-60.3%
AMZN NewAMAZON COM INC$516,4505,000
+100.0%
0.32%
EEM NewISHARES TRmsci emg mkt etf$493,00012,500
+100.0%
0.30%
BUR BuyBURFORD CAP LTD$486,640
+70.6%
44,000
+25.7%
0.30%
+54.4%
BA NewBOEING CO$477,9702,250
+100.0%
0.29%
C NewCITIGROUP INC$339,9507,250
+100.0%
0.21%
EOG NewEOG RES INC$275,1102,400
+100.0%
0.17%
SPOT NewSPOTIFY TECHNOLOGY S A$267,2402,000
+100.0%
0.16%
OI NewO-I GLASS INC$261,17011,500
+100.0%
0.16%
SBUX NewSTARBUCKS CORP$208,2602,000
+100.0%
0.13%
EVTCY NewEVOTEC AGsponsored ads$129,46012,388
+100.0%
0.08%
UNG NewUNITED STS NAT GAS FD LPunit par$104,10015,000
+100.0%
0.06%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
INTRA-CELLULAR THERAPIES INC16Q3 202310.2%
MICRON TECHNOLOGY INC16Q3 20236.7%
ALPHABET INC16Q3 20235.8%
ABBVIE INC16Q3 20237.9%
REGENERON PHARMACEUTICALS16Q3 20235.5%
ARGENX SE16Q3 20236.4%
SPDR GOLD TRUST16Q3 20236.6%
XENCOR INC16Q3 20234.1%
BK OF AMERICA CORP16Q3 20235.4%
ORACLE CORP16Q3 20233.2%

View DCF Advisers, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-13
13F-HR2023-08-09
13F-HR2023-05-15
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-13
13F-HR2022-02-10
13F-HR2021-11-15

View DCF Advisers, LLC's complete filings history.

Compare quarters

Export DCF Advisers, LLC's holdings